Business
Imaging3 Announces Denial of Vuksich Application for Petition for Reconsideration of Denial of Petition for Writ of Certiorari by the United States Supreme Court
Imaging3 Announces Denial of Vuksich Application for Petition for Reconsideration of Denial of Petition for Writ of Certiorari by the United States Supreme Court.
About this update from Grapefruit Usa Inc.
[{"type":"text","content":"\n\n BURBANK, Calif., Dec. 08, 2016 (GLOBE NEWSWIRE) -- Imaging3, Inc. (OTCQB:IGNG) announced today that the United States Supreme Court denied John M. Vuksich’s petition for a rehearing of an order denying a petition for a writ of certiorari in connection with the Supreme Court’s denial of Vuksich’s previous petition for a writ of certiorari.\n In April 2016, Vuksich appealed to the Supreme Court for a writ of certiorari on the Ninth Circuit rulings that would dismiss all of his appeals of holdings against him in his various actions against Imaging3. On October 3, 2016, the Supreme Court denied Vuksich’s application. On October 25, 2016, Vuksich filed a petition for a rehearing of the order denying a petition for a writ of certiorari. On December 6, 2016, The Supreme Court denied this petition. As a result, the Vuksich litigation against Imaging3 is now definitively terminated. About Imaging3 Imaging3, Inc., founded in 1993, has developed a patented medical imaging technology, called SmartScan™, that will produce 3D medical images in virtual real time. The SmartScan technology will allow healthcare professionals to perform diagnostic and therapeutic procedures more quickly and accurately, with fewer safety risks for the patient. In addition, Imaging3’s technology exposes patients to significantly less harmful radiation than current imaging technologies such as CT scans, which the company believes will allow scans to be used in more pediatric applications than are currently prescribed. The technology also allows for greater portability, easier installation, and a significantly reduced cost burden for the healthcare system overall. Imaging3 is planning to submit a 510K application to the FDA during 2017 in order to gain approval to commercialize the SmartScan technology. Visit the company’s website at http://www.imaging3.com for detailed information about the Company’s technology. Safe Harbor Statement Imaging3 cautions you that any statement included in this press release that is not a description of historical facts is a forward-looking statement. Many of these forward-looking statements contain the words \"anticipate,\" \"believe,\" \"estimate,\" \"may\" \"intend,\" \"expect\" and similar expressions. Actual results, performance or achievements could differ materially from those ...